1293010

Amgen Inc. — FEI 3003750095

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 6, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Louisville, KY (United States)